DurrDerma Healthcare

DurrDerma Healthcare is a German consumer healthcare and biopharmaceutical company focused on developing and commercializing natural, plant-based dermatological treatments. The company's flagship product, DurrDerma Rezeptur P, is a patented topical cream formulated with a synergistic combination of black cumin oil, olive oil, tea tree oil, cocoa butter, vitamin A, and vitamin B12. It is marketed as a cortisone-free, side-effect-free alternative for the complementary treatment of moderate to severe psoriasis. Clinical evaluations, including a case series documented in collaboration with the Charité - Universitätsmedizin Berlin, have demonstrated significant efficacy, with over 80% of patients achieving a 75% or greater reduction in their Psoriasis Area and Severity Index (PASI) score. DurrDerma also holds patents for compositions targeting other dermatological conditions, such as acne and warts.